Page last updated: 2024-08-24

pazufloxacin and Gonorrhea

pazufloxacin has been researched along with Gonorrhea in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kabayashi, I; Kumazawa, J; Matsumoto, T; Saika, T; Sakumoto, M; Takahashi, K; Tanaka, M	1

Other Studies

1 other study(ies) available for pazufloxacin and Gonorrhea

Article	Year
Reduced clinical efficacy of pazufloxacin against gonorrhea due to high prevalence of quinolone-resistant isolates with the GyrA mutation. The Pazufloxacin STD Group. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:3 Topics: Adult; Anti-Infective Agents; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Fluoroquinolones; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Neisseria gonorrhoeae; Oxazines; Treatment Outcome	1998

Article

Year

Reduced clinical efficacy of pazufloxacin against gonorrhea due to high prevalence of quinolone-resistant isolates with the GyrA mutation. The Pazufloxacin STD Group.

Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:3

Topics: Adult; Anti-Infective Agents; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Fluoroquinolones; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Neisseria gonorrhoeae; Oxazines; Treatment Outcome

1998